Research

Hormonal

Semaglutide use is associated with oral adverse effects, specifically xerostomia (dry mouth) and hyposalivation, likely due to prolonged GLP-1 receptor activation disrupting salivary gland signaling.

If you are taking semaglutide and experience persistent dry mouth, do not assume it is solely due to dehydration. The drug's prolonged action on salivary glands can reduce saliva production directly. Consult your provider for preventive oral care strategies to manage this side effect.

ModerateSupportsMEDIUM confidence
This review addresses the growing concern of oral side effects, particularly dry mouth, associated with semaglutide... Clinical pharmacovigilance data indicate disproportionality signals, suggesting that semaglutide may be reported more frequently with oral side effects compared with other GLP-1 receptor agonists
M Barac et al. · Biology · 2025

Why this rating

Based on narrative synthesis of transcriptomics, pharmacokinetics, and pharmacovigilance, but explicitly states no direct experimental confirmation in human salivary glands.

Source

GLP-1 Receptor Signaling and Oral Dysfunction: A Narrative Review on the Mechanistic Basis of Semaglutide-Related Oral Adverse Effects

M Barac et al. · Biology · 2025

DOI 10.3390/biology14121650

narrative_reviewCited 2×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →